Serum N-terminal atrial natriuretic peptide in adult patients late after surgical repair of atrial septal defect
Background: The purpose of surgical closure of atrial septal defect (ASD) is to relieve the cardiovascular system from a haemodynamic burden. Excessive amounts of atrial peptides are released in congestive heart failure, valvular diseases and congenital heart diseases. Aims: To examine whether patie...
Saved in:
Published in | European journal of heart failure Vol. 2; no. 2; pp. 161 - 165 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.06.2000
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 1388-9842 1879-0844 |
DOI | 10.1016/S1388-9842(00)00076-3 |
Cover
Abstract | Background:
The purpose of surgical closure of atrial septal defect (ASD) is to relieve the cardiovascular system from a haemodynamic burden. Excessive amounts of atrial peptides are released in congestive heart failure, valvular diseases and congenital heart diseases.
Aims:
To examine whether patients after surgical repair of ASD have higher concentrations of N-terminal atrial natriuretic peptide (ANP-N) than age-, sex- and body mass index (BMI)-matched control subjects.
Methods:
Medical history, physical examination, standard 12-lead electrocardiogram, and ANP-N concentrations were obtained in 65 adult patients operated for ASD at the age of 21 ± 13 years (mean ± standard deviation), 21 ± 6 years after surgical closure of ASD. Sixty-seven healthy subjects matched for age, sex and BMI served as controls.
Results:
In the patients serum ANP-N was higher than in the control subjects 0.41 ± 0.32 nmol/l, median 0.31 nmol/l, interquartile range (IQR) 0.21-0.49 nmol/l vs. 0.24 ± 0.12 nmol/l, median 0.23 nmol/l, IQR 0.17-0.29 nmol/l, (P = 0.0003). Patients with concomitant diseases had higher ANP-N concentrations (0.51 ± 0.39 nmol/l, median 0.34, IQR 0.26-0.73 nmol/l) than ASD patients without any history or signs of disease (0.28 ± 0.16 nmol/l, median 0.27, IQR 0.17-0.40 nmol/l, P = 0.01). The 'healthy' ASD patients had higher hormone concentrations than age-, sex- and BMI-matched control subjects (0.28 ± 0.16 median 0.27 nmol/l, IQR 0.17-0.40 nmol/l and 0.21 ± 0.07 nmol/l, median 0.20 nmol/l, IQR 0.15-0.27 nmol/l, P = 0.01). Multiple stepwise linear regression analysis showed that age at operation was strongly associated with the post-operative ANP-N concentration (r
2 = 0.25, P = 0.0002).
Conclusion:
ASD patients have higher ANP-N concentrations late after surgical repair. Hormone levels correlate with age at operation. Our finding supports the clinical praxis of operating on these patients in their childhood and adolescence. |
---|---|
AbstractList | The purpose of surgical closure of atrial septal defect (ASD) is to relieve the cardiovascular system from a haemodynamic burden. Excessive amounts of atrial peptides are released in congestive heart failure, valvular diseases and congenital heart diseases.
To examine whether patients after surgical repair of ASD have higher concentrations of N-terminal atrial natriuretic peptide (ANP-N) than age-, sex- and body mass index (BMI)-matched control subjects.
Medical history, physical examination, standard 12-lead electrocardiogram, and ANP-N concentrations were obtained in 65 adult patients operated for ASD at the age of 21+/-13 years (mean+/-standard deviation), 21+/-6 years after surgical closure of ASD. Sixty-seven healthy subjects matched for age, sex and BMI served as controls.
In the patients serum ANP-N was higher than in the control subjects 0.41+/-0.32 nmol/l, median 0.31 nmol/l, interquartile range (IQR) 0.21-0.49 nmol/l vs. 0.24+/-0.12 nmol/l, median 0.23 nmol/l, IQR 0.17-0.29 nmol/l, (P=0.0003). Patients with concomitant diseases had higher ANP-N concentrations (0.51+/-0.39 nmol/l, median 0.34, IQR 0.26-0.73 nmol/l) than ASD patients without any history or signs of disease (0.28+/-0.16 nmol/l, median 0.27, IQR 0.17-0.40 nmol/l, P=0.01). The 'healthy' ASD patients had higher hormone concentrations than age-, sex- and BMI-matched control subjects (0.28+/-0.16 median 0.27 nmol/l, IQR 0. 17-0.40 nmol/l and 0.21+/-0.07 nmol/l, median 0.20 nmol/l, IQR 0. 15-0.27 nmol/l, P=0.01). Multiple stepwise linear regression analysis showed that age at operation was strongly associated with the post-operative ANP-N concentration (r(2)=0.25, P=0.0002).
ASD patients have higher ANP-N concentrations late after surgical repair. Hormone levels correlate with age at operation. Our finding supports the clinical praxis of operating on these patients in their childhood and adolescence. The purpose of surgical closure of atrial septal defect (ASD) is to relieve the cardiovascular system from a haemodynamic burden. Excessive amounts of atrial peptides are released in congestive heart failure, valvular diseases and congenital heart diseases.BACKGROUNDThe purpose of surgical closure of atrial septal defect (ASD) is to relieve the cardiovascular system from a haemodynamic burden. Excessive amounts of atrial peptides are released in congestive heart failure, valvular diseases and congenital heart diseases.To examine whether patients after surgical repair of ASD have higher concentrations of N-terminal atrial natriuretic peptide (ANP-N) than age-, sex- and body mass index (BMI)-matched control subjects.AIMSTo examine whether patients after surgical repair of ASD have higher concentrations of N-terminal atrial natriuretic peptide (ANP-N) than age-, sex- and body mass index (BMI)-matched control subjects.Medical history, physical examination, standard 12-lead electrocardiogram, and ANP-N concentrations were obtained in 65 adult patients operated for ASD at the age of 21+/-13 years (mean+/-standard deviation), 21+/-6 years after surgical closure of ASD. Sixty-seven healthy subjects matched for age, sex and BMI served as controls.METHODSMedical history, physical examination, standard 12-lead electrocardiogram, and ANP-N concentrations were obtained in 65 adult patients operated for ASD at the age of 21+/-13 years (mean+/-standard deviation), 21+/-6 years after surgical closure of ASD. Sixty-seven healthy subjects matched for age, sex and BMI served as controls.In the patients serum ANP-N was higher than in the control subjects 0.41+/-0.32 nmol/l, median 0.31 nmol/l, interquartile range (IQR) 0.21-0.49 nmol/l vs. 0.24+/-0.12 nmol/l, median 0.23 nmol/l, IQR 0.17-0.29 nmol/l, (P=0.0003). Patients with concomitant diseases had higher ANP-N concentrations (0.51+/-0.39 nmol/l, median 0.34, IQR 0.26-0.73 nmol/l) than ASD patients without any history or signs of disease (0.28+/-0.16 nmol/l, median 0.27, IQR 0.17-0.40 nmol/l, P=0.01). The 'healthy' ASD patients had higher hormone concentrations than age-, sex- and BMI-matched control subjects (0.28+/-0.16 median 0.27 nmol/l, IQR 0. 17-0.40 nmol/l and 0.21+/-0.07 nmol/l, median 0.20 nmol/l, IQR 0. 15-0.27 nmol/l, P=0.01). Multiple stepwise linear regression analysis showed that age at operation was strongly associated with the post-operative ANP-N concentration (r(2)=0.25, P=0.0002).RESULTSIn the patients serum ANP-N was higher than in the control subjects 0.41+/-0.32 nmol/l, median 0.31 nmol/l, interquartile range (IQR) 0.21-0.49 nmol/l vs. 0.24+/-0.12 nmol/l, median 0.23 nmol/l, IQR 0.17-0.29 nmol/l, (P=0.0003). Patients with concomitant diseases had higher ANP-N concentrations (0.51+/-0.39 nmol/l, median 0.34, IQR 0.26-0.73 nmol/l) than ASD patients without any history or signs of disease (0.28+/-0.16 nmol/l, median 0.27, IQR 0.17-0.40 nmol/l, P=0.01). The 'healthy' ASD patients had higher hormone concentrations than age-, sex- and BMI-matched control subjects (0.28+/-0.16 median 0.27 nmol/l, IQR 0. 17-0.40 nmol/l and 0.21+/-0.07 nmol/l, median 0.20 nmol/l, IQR 0. 15-0.27 nmol/l, P=0.01). Multiple stepwise linear regression analysis showed that age at operation was strongly associated with the post-operative ANP-N concentration (r(2)=0.25, P=0.0002).ASD patients have higher ANP-N concentrations late after surgical repair. Hormone levels correlate with age at operation. Our finding supports the clinical praxis of operating on these patients in their childhood and adolescence.CONCLUSIONASD patients have higher ANP-N concentrations late after surgical repair. Hormone levels correlate with age at operation. Our finding supports the clinical praxis of operating on these patients in their childhood and adolescence. Background: The purpose of surgical closure of atrial septal defect (ASD) is to relieve the cardiovascular system from a haemodynamic burden. Excessive amounts of atrial peptides are released in congestive heart failure, valvular diseases and congenital heart diseases. Aims: To examine whether patients after surgical repair of ASD have higher concentrations of N-terminal atrial natriuretic peptide (ANP-N) than age-, sex- and body mass index (BMI)-matched control subjects. Methods: Medical history, physical examination, standard 12-lead electrocardiogram, and ANP-N concentrations were obtained in 65 adult patients operated for ASD at the age of 21 ± 13 years (mean ± standard deviation), 21 ± 6 years after surgical closure of ASD. Sixty-seven healthy subjects matched for age, sex and BMI served as controls. Results: In the patients serum ANP-N was higher than in the control subjects 0.41 ± 0.32 nmol/l, median 0.31 nmol/l, interquartile range (IQR) 0.21-0.49 nmol/l vs. 0.24 ± 0.12 nmol/l, median 0.23 nmol/l, IQR 0.17-0.29 nmol/l, (P = 0.0003). Patients with concomitant diseases had higher ANP-N concentrations (0.51 ± 0.39 nmol/l, median 0.34, IQR 0.26-0.73 nmol/l) than ASD patients without any history or signs of disease (0.28 ± 0.16 nmol/l, median 0.27, IQR 0.17-0.40 nmol/l, P = 0.01). The 'healthy' ASD patients had higher hormone concentrations than age-, sex- and BMI-matched control subjects (0.28 ± 0.16 median 0.27 nmol/l, IQR 0.17-0.40 nmol/l and 0.21 ± 0.07 nmol/l, median 0.20 nmol/l, IQR 0.15-0.27 nmol/l, P = 0.01). Multiple stepwise linear regression analysis showed that age at operation was strongly associated with the post-operative ANP-N concentration (r 2 = 0.25, P = 0.0002). Conclusion: ASD patients have higher ANP-N concentrations late after surgical repair. Hormone levels correlate with age at operation. Our finding supports the clinical praxis of operating on these patients in their childhood and adolescence. Background: The purpose of surgical closure of atrial septal defect (ASD) is to relieve the cardiovascular system from a haemodynamic burden. Excessive amounts of atrial peptides are released in congestive heart failure, valvular diseases and congenital heart diseases. Aims: To examine whether patients after surgical repair of ASD have higher concentrations of N‐terminal atrial natriuretic peptide (ANP‐N) than age‐, sex‐ and body mass index (BMI)‐matched control subjects. Methods: Medical history, physical examination, standard 12‐lead electrocardiogram, and ANP‐N concentrations were obtained in 65 adult patients operated for ASD at the age of 21 ± 13 years (mean ± standard deviation), 21 ± 6 years after surgical closure of ASD. Sixty‐seven healthy subjects matched for age, sex and BMI served as controls. Results: In the patients serum ANP‐N was higher than in the control subjects 0.41 ± 0.32 nmol/l, median 0.31 nmol/l, interquartile range (IQR) 0.21–0.49 nmol/l vs. 0.24 ± 0.12 nmol/l, median 0.23 nmol/l, IQR 0.17–0.29 nmol/l, (P = 0.0003). Patients with concomitant diseases had higher ANP‐N concentrations (0.51 ± 0.39 nmol/l, median 0.34, IQR 0.26–0.73 nmol/l) than ASD patients without any history or signs of disease (0.28 ± 0.16 nmol/l, median 0.27, IQR 0.17–0.40 nmol/l, P = 0.01). The ‘healthy’ ASD patients had higher hormone concentrations than age‐, sex‐ and BMI‐matched control subjects (0.28 ± 0.16 median 0.27 nmol/l, IQR 0.17–0.40 nmol/l and 0.21 ± 0.07 nmol/l, median 0.20 nmol/l, IQR 0.15–0.27 nmol/l, P = 0.01). Multiple stepwise linear regression analysis showed that age at operation was strongly associated with the post‐operative ANP‐N concentration (r2 = 0.25, P = 0.0002). Conclusion: ASD patients have higher ANP‐N concentrations late after surgical repair. Hormone levels correlate with age at operation. Our finding supports the clinical praxis of operating on these patients in their childhood and adolescence. |
Author | Groundstroem, Kaj W.E. Uusitalo, Arto Talvensaari, Taisto J. Lahtela, Jorma T. Pasternack, Amos Iivainen, Tiina E. |
Author_xml | – sequence: 1 givenname: Tiina E. surname: Iivainen fullname: Iivainen, Tiina E. email: kljola@uta.fi organization: Department of Clinical Physiology, Tampere University Hospital, P.O. Box 2000, FIN-33520, Tampere, Finland – sequence: 2 givenname: Kaj W.E. surname: Groundstroem fullname: Groundstroem, Kaj W.E. organization: Department of Internal Medicine, Tampere University Hospital, Tampere, Finland – sequence: 3 givenname: Jorma T. surname: Lahtela fullname: Lahtela, Jorma T. organization: Department of Internal Medicine, Tampere University Hospital, Tampere, Finland – sequence: 4 givenname: Taisto J. surname: Talvensaari fullname: Talvensaari, Taisto J. organization: Department of Internal Medicine, Tampere University Hospital, Tampere, Finland – sequence: 5 givenname: Amos surname: Pasternack fullname: Pasternack, Amos organization: Department of Internal Medicine, Tampere University Hospital, Tampere, Finland – sequence: 6 givenname: Arto surname: Uusitalo fullname: Uusitalo, Arto organization: Department of Clinical Physiology, Tampere University Hospital, P.O. Box 2000, FIN-33520, Tampere, Finland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/10856729$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkUmLFTEUhYO02JM_QclKdBG9qdSQQmiQZ4807aLVtwypyo1EazJJof3vzevq54Rgr04W33cC5-6TnWEckJAnHF5y4OWray6kZLXMs-cALwCgKpl4QPa4rGoGMs930nuL7JL9ED4D8Aoge0R2OciirLJ6j0zX6OeeXrGIvneD7qiO3qUYNjl7jK6lE07RGaRuoNrMXaSTjg6HGGinI1Jtk0zD7D-5NpkeJ-08He22KiQ9hUGLbTwkD63uAj6-ywPy4eT4_eqMXb47PV-9uWRtIblgFXJscplDXfCmbqsmF2iNlWA5cgApRV031nBjNIrWFKYstEbkxubGNlkpDsizpXfy49cZQ1S9Cy12nR5wnIOqeFaUWV4k8OkdODc9GjV512t_o7YbJaBYgNaPIXi0vyFqcwt1ewu1GVoBqNtbKJG81395rYtpuHGIXrvuv_bRYn9zHd7c70t1fHF28qsAloJxnv6tsz90tlHYorgQ8ftPSfsvqqxEVaj11alavV2n7dYflRQ_ACHTv6Q |
CitedBy_id | crossref_primary_10_1016_j_ijcard_2005_07_019 crossref_primary_10_1016_j_ijcard_2005_07_025 crossref_primary_10_1161_CIRCULATIONAHA_105_594218 crossref_primary_10_1016_j_ccl_2006_08_002 crossref_primary_10_1016_j_cyto_2011_10_002 crossref_primary_10_1042_CS20040141 crossref_primary_10_1161_01_CIR_0000020009_30736_3F crossref_primary_10_1016_S0167_5273_02_00427_8 crossref_primary_10_1007_s10072_009_0094_y crossref_primary_10_1155_2010_674575 crossref_primary_10_1586_erc_13_14 crossref_primary_10_1111_j_1526_4610_2012_02152_x crossref_primary_10_1016_j_ijcard_2004_08_005 crossref_primary_10_1046_j_1526_4610_2003_03096_x crossref_primary_10_1002_ccd_20962 crossref_primary_10_5507_bp_2010_006 crossref_primary_10_1017_S1047951103000520 crossref_primary_10_1586_14779072_4_1_33 crossref_primary_10_2459_01_JCM_0000247442_79644_90 |
Cites_doi | 10.1097/00004872-199309000-00004 10.1161/01.HYP.10.6.570 10.1016/S0002-9149(88)80080-8 10.1007/BF02083294 10.1161/01.CIR.89.5.1934 10.1093/oxfordjournals.eurheartj.a014759 10.1046/j.1365-2796.1997.113124000.x 10.1111/paa.1999.111.5.406 10.1161/01.CIR.93.11.1946 10.1111/j.1651-2227.1987.tb10541.x 10.1016/0002-9149(93)90192-F 10.1097/00003246-199411000-00009 10.1542/peds.82.4.639 10.1136/hrt.24.5.557 10.1056/NEJM199012133232401 10.1016/S0022-3476(87)80450-X 10.1016/1010-7940(93)90052-D 10.1203/00006450-198612000-00029 |
ContentType | Journal Article |
Copyright | 2000 European Society of Cardiology 2000 Published on behalf of the European Society of Cardiology. All rights reserved. © 2000 the Authors |
Copyright_xml | – notice: 2000 European Society of Cardiology 2000 – notice: Published on behalf of the European Society of Cardiology. All rights reserved. © 2000 the Authors |
DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/S1388-9842(00)00076-3 |
DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-0844 |
EndPage | 165 |
ExternalDocumentID | 10856729 10_1016_S1388_9842_00_00076_3 EJHF00076-3 10.1016/S1388-9842(00)00076-3 ark_67375_WNG_CDW712WV_8 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K .I3 0R~ 1B1 1OC 1~5 24P 29G 2WC 33P 4G. 53G 5GY 5VS 6PF 7-5 70D AAESR AAHHS AANLZ AAPNW AASGY AAWTL AAXRX AAZKR ABCUV ABDBF ABJNI ABKDP ABLJU ABQWH ABXGK ABZBJ ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACXBN ACXQS ADBBV ADBTR ADEOM ADEYI ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AENEX AEQDE AEUYR AFBPY AFFPM AFGKR AFPWT AGKEF AHBTC AIACR AIJHB AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG AVWKF AZFZN AZVAB BDRZF BFHJK BHBCM BMXJE BRXPI BSCLL C45 CKLRP CS3 CZ4 DCZOG DRFUL DRMAN DRSTM DU5 E3Z EBD EBS EJD EMOBN ESX F5P FEDTE FUBAC G-S GODZA H13 HGLYW HVGLF HZ~ IHE IPNFZ KBYEO LATKE LEEKS LITHE LOXES LUTES LYRES M41 M49 MEWTI MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N9A NQ- NU- O0~ O66 O9- OK1 OVD O~Y P2P P2W Q1. RD5 RIG ROL RPZ RXO SDG SEL SEW SUPJJ SV3 TEORI TUS UHS V9Y W8F WBKPD WHWMO WIH WIJ WIK WIN WOHZO WVDHM WXSBR WYJ X7H ~91 AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACUHS ACYXJ ADNMO AFWVQ ALVPJ AAFWJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7X8 AAMMB AEFGJ AGXDD AIDQK AIDYY LH4 |
ID | FETCH-LOGICAL-c5813-7e1eb4840951b9c7b43efdf80f1e10088399bfd1ddae3cd5d65aaee1df4dfb263 |
ISSN | 1388-9842 |
IngestDate | Thu Sep 04 18:24:50 EDT 2025 Wed Feb 19 02:34:32 EST 2025 Tue Jul 01 01:12:15 EDT 2025 Thu Apr 24 22:59:11 EDT 2025 Wed Jan 22 16:22:01 EST 2025 Wed Aug 28 03:24:42 EDT 2024 Wed Oct 30 09:56:06 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Heart Atrial septal defect Haemodynamics Congenital heart defect Surgery Natriuretic peptide |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c5813-7e1eb4840951b9c7b43efdf80f1e10088399bfd1ddae3cd5d65aaee1df4dfb263 |
Notes | istex:F10B8036D13165D530204D65121B86B2ED5D91DF ArticleID:EJHF00076-3 ark:/67375/WNG-CDW712WV-8 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/S1388-9842%2800%2900076-3 |
PMID | 10856729 |
PQID | 71256245 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_71256245 pubmed_primary_10856729 crossref_primary_10_1016_S1388_9842_00_00076_3 crossref_citationtrail_10_1016_S1388_9842_00_00076_3 wiley_primary_10_1016_S1388_9842_00_00076_3_EJHF00076_3 oup_primary_10_1016_S1388-9842_00_00076-3 istex_primary_ark_67375_WNG_CDW712WV_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | June 2000 |
PublicationDateYYYYMMDD | 2000-06-01 |
PublicationDate_xml | – month: 06 year: 2000 text: June 2000 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | European journal of heart failure |
PublicationTitleAlternate | European Journal of Heart Failure |
PublicationYear | 2000 |
Publisher | Blackwell Publishing Ltd Elsevier |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Elsevier |
References | MeijboomFHessJSzatmariA et al. Long-term follow-up (9 to 20 years) after surgical closure of atrial septal defect at a young ageAm J Cardiol19937214311434 BonowR.ONew insights into the cardiac natriuretic peptidesCirculation19969319461950 SamanekMSlavikZZborilovaBHrobonovaVVoriskovaMSkovranekJPrevalence, treatment, and outcome of heart disease in live-born children: a prospective analysis of 91,823 live-born childrenPediatr Cardiol198910205211 HallCRouleauJ.LMoyèL et al. N-Terminal proatrial natriuretic factor. an independent predictor of long-term prognosis after myocardial infarctionCirculation19948919341942 AgnolettiGScottiCPanzaliA.F et al. Plasma levels of atrial natriuretic factor (ANF) and urinary excretion of ANF, arginine vasopressin and catecholamines in children with congenital heart disease: effect of cardiac surgeryEur J Cardio-thorac Surg19937533539 SiltanenP. Atrial septal defect of secundum type in adults. Acta Med Scand 1968;497(Suppl):1-151. MurphyJ.GGershB.JMcGoonM.D et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 yearsN Engl J Med199032316451650 UchiyamaMSatokataISakaiKPlasma atrial natriuretic peptide in congenital heart diseaseActa Paediatr198776669670 Espino-VelaJAlvarado-ToroANatural history of atrial septal defectCardiovasc Clin19712103125 GuidelinesSub-Committee1993 Guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meetingJ Hypertens199311905918 HuysmansH.AVrakkingMvan BovenW.J.PLate follow-up after surgical correction of atrial septal defect of the secundum typeZ Kardiol19897Suppl4345 KindelanA.ANaveroJ.L.PDe La RosaI.IRuizM.CLopezP.MLezcanoA.RRelationship between hemodynamic changes and blood hormone concentrations after cardiac surgery in children with congenital heart diseaseCrit Care Med19942217541761 KikuchiKNishiokaKUedaT et al. Relationship between plasma atrial natriuretic polypeptide concentration and hemodynamic measurements in children with congenital heart diseasesJ Pediatr1987111335342 HolmströmHThaulowEStokkeOLindbergHHallCSerum N-terminal proatrial natriuretic factor in children with congenital heart diseaseEur Heart J19961717371746 BidlingmaierJ.WDöhlemannCKuhnleUStromTLangR.EComparison of plasma atrial natriuretic peptide levels in healthy children from birth to adolescence and in children with cardiac diseasesPediatr Res19862013281331 ChenH.HBurnettJ.CThe natriuretic peptides in heart failure: diagnostic and therapeutic potentialsProc Assoc Am Phys1999111406416 IivanainenA.MTikkanenITilvisRHeikkiläJHeleniusTKupariMAssociations between atrial natriuretic peptides, echocardiographic findings and mortality in an elderly population sampleJ Intern Med1997241261268 MontorsiPTonoloGPoloniaJHepburnDRichardsMCorrelates of plasma atrial natriuretic factor in health and hypertensionHypertension198710570576 MatsuokaSKurahashiYMikiY et al. Plasma atrial natriuretic peptide in patients with congenital heart diseasesPediatrics198882639643 LangR.EDietzRMerkelAUngerTRuskoahoHGantenDPlasma atrial natriuretic peptide values in cardiac diseaseJ Hypertens19864Suppl 2119123 The declaration of HelsinkiBr Med J1964II177 TikkanenIHeleniusTHeinänenTSoveriPN-terminal atrial natriuretic peptide (ANP-N) in heart failure [Abstr.]Scand J Clin Lab Invest199555Suppl 223645 SeldonW.ARubinsteinCFraserA.AThe incidence of atrial septal defect in adultsBr Heart J196224557560 FyhrquistFTikkanenIAtrial natriuretic peptide in congestive heart failureAm J Cardiol19886220A24A 1993; 7 1987; 76 1996; 17 1987; 10 1990; 323 1989; 10 1987; 111 1968; 497 1993; 72 1986; 20 1989; 7 1993; 11 1997; 241 1986; 4 1995; 55 1994; 89 1996; 93 1964; II 1994; 22 1962; 24 1988; 62 1999; 111 1971; 2 1988; 82 e_1_2_6_21_1 e_1_2_6_10_1 Lang R.E (e_1_2_6_15_1) 1986; 4 e_1_2_6_20_1 Matsuoka S (e_1_2_6_13_1) 1988; 82 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_19_1 (e_1_2_6_18_1) 1964 e_1_2_6_5_1 Tikkanen I (e_1_2_6_17_1) 1995; 55 Huysmans H.A (e_1_2_6_7_1) 1989; 7 Siltanen P (e_1_2_6_6_1) 1968; 497 e_1_2_6_25_1 Espino‐Vela J (e_1_2_6_4_1) 1971; 2 e_1_2_6_14_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_11_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_12_1 e_1_2_6_22_1 e_1_2_6_16_1 |
References_xml | – reference: ChenH.HBurnettJ.CThe natriuretic peptides in heart failure: diagnostic and therapeutic potentialsProc Assoc Am Phys1999111406416 – reference: HallCRouleauJ.LMoyèL et al. N-Terminal proatrial natriuretic factor. an independent predictor of long-term prognosis after myocardial infarctionCirculation19948919341942 – reference: SeldonW.ARubinsteinCFraserA.AThe incidence of atrial septal defect in adultsBr Heart J196224557560 – reference: HuysmansH.AVrakkingMvan BovenW.J.PLate follow-up after surgical correction of atrial septal defect of the secundum typeZ Kardiol19897Suppl4345 – reference: MeijboomFHessJSzatmariA et al. Long-term follow-up (9 to 20 years) after surgical closure of atrial septal defect at a young ageAm J Cardiol19937214311434 – reference: LangR.EDietzRMerkelAUngerTRuskoahoHGantenDPlasma atrial natriuretic peptide values in cardiac diseaseJ Hypertens19864Suppl 2119123 – reference: BidlingmaierJ.WDöhlemannCKuhnleUStromTLangR.EComparison of plasma atrial natriuretic peptide levels in healthy children from birth to adolescence and in children with cardiac diseasesPediatr Res19862013281331 – reference: TikkanenIHeleniusTHeinänenTSoveriPN-terminal atrial natriuretic peptide (ANP-N) in heart failure [Abstr.]Scand J Clin Lab Invest199555Suppl 223645 – reference: IivanainenA.MTikkanenITilvisRHeikkiläJHeleniusTKupariMAssociations between atrial natriuretic peptides, echocardiographic findings and mortality in an elderly population sampleJ Intern Med1997241261268 – reference: FyhrquistFTikkanenIAtrial natriuretic peptide in congestive heart failureAm J Cardiol19886220A24A – reference: SiltanenP. Atrial septal defect of secundum type in adults. Acta Med Scand 1968;497(Suppl):1-151. – reference: HolmströmHThaulowEStokkeOLindbergHHallCSerum N-terminal proatrial natriuretic factor in children with congenital heart diseaseEur Heart J19961717371746 – reference: The declaration of HelsinkiBr Med J1964II177 – reference: KikuchiKNishiokaKUedaT et al. Relationship between plasma atrial natriuretic polypeptide concentration and hemodynamic measurements in children with congenital heart diseasesJ Pediatr1987111335342 – reference: KindelanA.ANaveroJ.L.PDe La RosaI.IRuizM.CLopezP.MLezcanoA.RRelationship between hemodynamic changes and blood hormone concentrations after cardiac surgery in children with congenital heart diseaseCrit Care Med19942217541761 – reference: BonowR.ONew insights into the cardiac natriuretic peptidesCirculation19969319461950 – reference: UchiyamaMSatokataISakaiKPlasma atrial natriuretic peptide in congenital heart diseaseActa Paediatr198776669670 – reference: MatsuokaSKurahashiYMikiY et al. Plasma atrial natriuretic peptide in patients with congenital heart diseasesPediatrics198882639643 – reference: GuidelinesSub-Committee1993 Guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meetingJ Hypertens199311905918 – reference: AgnolettiGScottiCPanzaliA.F et al. Plasma levels of atrial natriuretic factor (ANF) and urinary excretion of ANF, arginine vasopressin and catecholamines in children with congenital heart disease: effect of cardiac surgeryEur J Cardio-thorac Surg19937533539 – reference: Espino-VelaJAlvarado-ToroANatural history of atrial septal defectCardiovasc Clin19712103125 – reference: SamanekMSlavikZZborilovaBHrobonovaVVoriskovaMSkovranekJPrevalence, treatment, and outcome of heart disease in live-born children: a prospective analysis of 91,823 live-born childrenPediatr Cardiol198910205211 – reference: MurphyJ.GGershB.JMcGoonM.D et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 yearsN Engl J Med199032316451650 – reference: MontorsiPTonoloGPoloniaJHepburnDRichardsMCorrelates of plasma atrial natriuretic factor in health and hypertensionHypertension198710570576 – volume: 2 start-page: 103 year: 1971 end-page: 125 article-title: Natural history of atrial septal defect publication-title: Cardiovasc Clin – volume: 323 start-page: 1645 year: 1990 end-page: 1650 article-title: Long‐term outcome after surgical repair of isolated atrial septal defect. Follow‐up at 27 to 32 years publication-title: N Engl J Med – volume: 10 start-page: 570 year: 1987 end-page: 576 article-title: Correlates of plasma atrial natriuretic factor in health and hypertension publication-title: Hypertension – volume: 497 start-page: 1 issue: Suppl year: 1968 end-page: 151 article-title: Atrial septal defect of secundum type in adults publication-title: Acta Med Scand – volume: 72 start-page: 1431 year: 1993 end-page: 1434 article-title: Long‐term follow‐up (9 to 20 years) after surgical closure of atrial septal defect at a young age publication-title: Am J Cardiol – volume: 17 start-page: 1737 year: 1996 end-page: 1746 article-title: Serum N‐terminal proatrial natriuretic factor in children with congenital heart disease publication-title: Eur Heart J – volume: 89 start-page: 1934 year: 1994 end-page: 1942 article-title: N‐Terminal proatrial natriuretic factor. an independent predictor of long‐term prognosis after myocardial infarction publication-title: Circulation – volume: 111 start-page: 406 year: 1999 end-page: 416 article-title: The natriuretic peptides in heart failure: diagnostic and therapeutic potentials publication-title: Proc Assoc Am Phys – volume: 111 start-page: 335 year: 1987 end-page: 342 article-title: Relationship between plasma atrial natriuretic polypeptide concentration and hemodynamic measurements in children with congenital heart diseases publication-title: J Pediatr – volume: 22 start-page: 1754 year: 1994 end-page: 1761 article-title: Relationship between hemodynamic changes and blood hormone concentrations after cardiac surgery in children with congenital heart disease publication-title: Crit Care Med – volume: 241 start-page: 261 year: 1997 end-page: 268 article-title: Associations between atrial natriuretic peptides, echocardiographic findings and mortality in an elderly population sample publication-title: J Intern Med – volume: 76 start-page: 669 year: 1987 end-page: 670 article-title: Plasma atrial natriuretic peptide in congenital heart disease publication-title: Acta Paediatr – volume: 93 start-page: 1946 year: 1996 end-page: 1950 article-title: New insights into the cardiac natriuretic peptides publication-title: Circulation – volume: 82 start-page: 639 year: 1988 end-page: 643 article-title: Plasma atrial natriuretic peptide in patients with congenital heart diseases publication-title: Pediatrics – volume: 62 start-page: 20A year: 1988 end-page: 24A article-title: Atrial natriuretic peptide in congestive heart failure publication-title: Am J Cardiol – volume: 10 start-page: 205 year: 1989 end-page: 211 article-title: Prevalence, treatment, and outcome of heart disease in live‐born children: a prospective analysis of 91,823 live‐born children publication-title: Pediatr Cardiol – volume: 7 start-page: 43 issue: Suppl year: 1989 end-page: 45 article-title: Late follow‐up after surgical correction of atrial septal defect of the secundum type publication-title: Z Kardiol – volume: 55 start-page: 645 issue: Suppl 223 year: 1995 article-title: N‐terminal atrial natriuretic peptide (ANP‐N) in heart failure [Abstr.] publication-title: Scand J Clin Lab Invest – volume: 20 start-page: 1328 year: 1986 end-page: 1331 article-title: Comparison of plasma atrial natriuretic peptide levels in healthy children from birth to adolescence and in children with cardiac diseases publication-title: Pediatr Res – volume: 24 start-page: 557 year: 1962 end-page: 560 article-title: The incidence of atrial septal defect in adults publication-title: Br Heart J – volume: 4 start-page: 119 issue: Suppl 2 year: 1986 end-page: 123 article-title: Plasma atrial natriuretic peptide values in cardiac disease publication-title: J Hypertens – volume: II start-page: 177 year: 1964 article-title: The declaration of Helsinki publication-title: Br Med J – volume: 11 start-page: 905 year: 1993 end-page: 918 article-title: 1993 Guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting publication-title: J Hypertens – volume: 7 start-page: 533 year: 1993 end-page: 539 article-title: Plasma levels of atrial natriuretic factor (ANF) and urinary excretion of ANF, arginine vasopressin and catecholamines in children with congenital heart disease: effect of cardiac surgery publication-title: Eur J Cardio‐thorac Surg – volume: 4 start-page: 119 issue: 2 year: 1986 ident: e_1_2_6_15_1 article-title: Plasma atrial natriuretic peptide values in cardiac disease publication-title: J Hypertens – volume: 7 start-page: 43 year: 1989 ident: e_1_2_6_7_1 article-title: Late follow‐up after surgical correction of atrial septal defect of the secundum type publication-title: Z Kardiol – ident: e_1_2_6_16_1 doi: 10.1097/00004872-199309000-00004 – ident: e_1_2_6_25_1 doi: 10.1161/01.HYP.10.6.570 – volume: 55 start-page: 645 issue: 223 year: 1995 ident: e_1_2_6_17_1 article-title: N‐terminal atrial natriuretic peptide (ANP‐N) in heart failure [Abstr.] publication-title: Scand J Clin Lab Invest – ident: e_1_2_6_19_1 doi: 10.1016/S0002-9149(88)80080-8 – ident: e_1_2_6_2_1 doi: 10.1007/BF02083294 – ident: e_1_2_6_21_1 doi: 10.1161/01.CIR.89.5.1934 – ident: e_1_2_6_14_1 doi: 10.1093/oxfordjournals.eurheartj.a014759 – ident: e_1_2_6_20_1 doi: 10.1046/j.1365-2796.1997.113124000.x – ident: e_1_2_6_9_1 doi: 10.1111/paa.1999.111.5.406 – start-page: 177 year: 1964 ident: e_1_2_6_18_1 article-title: The declaration of Helsinki publication-title: Br Med J – volume: 2 start-page: 103 year: 1971 ident: e_1_2_6_4_1 article-title: Natural history of atrial septal defect publication-title: Cardiovasc Clin – ident: e_1_2_6_10_1 doi: 10.1161/01.CIR.93.11.1946 – ident: e_1_2_6_11_1 doi: 10.1111/j.1651-2227.1987.tb10541.x – ident: e_1_2_6_8_1 doi: 10.1016/0002-9149(93)90192-F – ident: e_1_2_6_23_1 doi: 10.1097/00003246-199411000-00009 – volume: 82 start-page: 639 year: 1988 ident: e_1_2_6_13_1 article-title: Plasma atrial natriuretic peptide in patients with congenital heart diseases publication-title: Pediatrics doi: 10.1542/peds.82.4.639 – ident: e_1_2_6_3_1 doi: 10.1136/hrt.24.5.557 – ident: e_1_2_6_5_1 doi: 10.1056/NEJM199012133232401 – ident: e_1_2_6_12_1 doi: 10.1016/S0022-3476(87)80450-X – ident: e_1_2_6_24_1 doi: 10.1016/1010-7940(93)90052-D – volume: 497 start-page: 1 year: 1968 ident: e_1_2_6_6_1 article-title: Atrial septal defect of secundum type in adults publication-title: Acta Med Scand – ident: e_1_2_6_22_1 doi: 10.1203/00006450-198612000-00029 |
SSID | ssj0017002 |
Score | 1.7252208 |
Snippet | Background:
The purpose of surgical closure of atrial septal defect (ASD) is to relieve the cardiovascular system from a haemodynamic burden. Excessive amounts... The purpose of surgical closure of atrial septal defect (ASD) is to relieve the cardiovascular system from a haemodynamic burden. Excessive amounts of atrial... |
SourceID | proquest pubmed crossref wiley oup istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 161 |
SubjectTerms | Adult Aged Atrial Natriuretic Factor - blood Atrial septal defect Cardiac Surgical Procedures Congenital heart defect Female Haemodynamics Heart Heart Septal Defects, Atrial - blood Heart Septal Defects, Atrial - surgery Hemodynamics Humans Male Middle Aged Natriuretic peptide Postoperative Period Regression Analysis Surgery |
Title | Serum N-terminal atrial natriuretic peptide in adult patients late after surgical repair of atrial septal defect |
URI | https://api.istex.fr/ark:/67375/WNG-CDW712WV-8/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1016%2FS1388-9842%2800%2900076-3 https://www.ncbi.nlm.nih.gov/pubmed/10856729 https://www.proquest.com/docview/71256245 |
Volume | 2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKVkJcEG_K0weEWEUpedhNctxHS6nYXujSvUV24ohCNl21DUKc-An8Rk78DMaPPAq7YtlLWtmdSdT5Mh7bn2cQehGxJAgdL7GzJCI24VzYnNDIFtTJeMijjHO5o3s0HYyPyeSEnnQ6v1qspXLD-8m3c8-VXMWq0AZ2ladk_8OytVJogO9gX7iCheF6KRvDi16eWtOasGCYLbnFdDGOQn6W6pyidSbpK6lKEaJyblQZVddWDuGmqRW-LlfaE65glNIbCEbVGsTlfo6Q9I8Ll_NNaCurZG-sjC3ysuHWvl18YRDS6mrIC3hMa9hv2D-yutN6s1qKU83x-GTN-03_O_ZxI3JN61Wnp2Z114zl4K_XjOkj8zMmcyVYk_7WcobT0K6MB_bByFGoU271hW4Lg0gmoCVtt-210Om1XLCrk7ub0dzVlSj-Gij0msX7-m4Qzsuq2JHamrT9ZnSsGAG1EN0Wo1qQXiCqIoXhZDwyvddQ1wsCSSjo7u0f7o_qHa_A0fzYSnNz2ux1c7tXjrNrFG3FUV3pEr7-cUazNVXannmp0Gl2C900cx68pwF8G3VEcQddPzKsjrtopXCMpz-__6gQjDXscAvB2CAYLwqsEIwrBGOJYKwQjCsEY41gvMwqVRrBWCP4HjoeDWcHY9vUArETGrq-HQhXcCJXI6jLoyTgxBdZmoVO5gqZnwri_IhnqZumTPhJStMBZUwIN81ImnFv4N9HO8WyEA8RJhFE7QMXGmlGRCBCJ43AnyaUMB-GL7-HSPXPxolJlC_rteRxzYiUBomlQWJHZtcFg8Qg1q_FznSmmH8JvFRmq3_NVp8lzTKg8Xz6Jj44nAeuN_8Qhz20C3Y9X6m9pdQGpc8r68cwUMjdP1aIZbmOQRnMdQjtoQcaFC2FIR3AJLuHAoWSyz1-XKM69h9dWfIxutF4gSdoZ7MqxVMI8zf8mXlDfgPEae1S |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+N%E2%80%90terminal+atrial+natriuretic+peptide+in+adult+patients+late+after+surgical+repair+of+atrial+septal+defect&rft.jtitle=European+journal+of+heart+failure&rft.au=Iivainen%2C+Tiina+E.&rft.au=Groundstroem%2C+Kaj+W.E.&rft.au=Lahtela%2C+Jorma+T.&rft.au=Talvensaari%2C+Taisto+J.&rft.date=2000-06-01&rft.issn=1388-9842&rft.eissn=1879-0844&rft.volume=2&rft.issue=2&rft.spage=161&rft.epage=165&rft_id=info:doi/10.1016%2FS1388-9842%2800%2900076-3&rft.externalDBID=10.1016%252FS1388-9842%252800%252900076-3&rft.externalDocID=EJHF00076-3 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1388-9842&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1388-9842&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1388-9842&client=summon |